Skip to main
BSX
BSX logo

Boston Scientific (BSX) Stock Forecast & Price Target

Boston Scientific (BSX) Analyst Ratings

Based on 43 analyst ratings
Buy
Strong Buy 42%
Buy 42%
Hold 16%
Sell 0%
Strong Sell 0%

Bulls say

Boston Scientific's strong growth potential is underscored by the positive developments observed in its Electrophysiology and Watchman divisions, which are expected to enhance top-line performance and operating leverage. The company's ability to achieve faster-than-expected sales growth, alongside ongoing margin expansion due to increased gross margins and operational efficiencies, indicates a favorable outlook for earnings per share growth. Additionally, Boston Scientific's diversified product portfolio and consistent track record of exceeding organic growth expectations since 2021 further support a robust future in the MedTech sector.

Bears say

Boston Scientific's stock outlook appears negative due to projected gross margin declines of approximately 40 basis points year-over-year for 2024, primarily driven by limitations related to the capital sale energy generator system component. The company faces significant risks, including potential market share losses in critical areas such as electrophysiology and structural heart sales, compounded by weaker-than-expected operating margin improvements and a bear case assumption of revenue growth remaining below 10%. Additionally, concerns about complacency following a strong revenue growth year, alongside potential disruptions from COVID-19 and competitive pressures, further contribute to an uncertain financial trajectory for the firm.

Boston Scientific (BSX) has been analyzed by 43 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 42% recommend Buy, 16% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Boston Scientific and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Boston Scientific (BSX) Forecast

Analysts have given Boston Scientific (BSX) a Buy based on their latest research and market trends.

According to 43 analysts, Boston Scientific (BSX) has a Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Boston Scientific (BSX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.